Effects of the dutasteride and sildenafil association in the penis of a benign prostatic hyperplasia animal model
Objective: The aim of this study was to investigate whether concomitant treatment of dutasteride and sildenafil could prevent structural changes in the penis of a BPH rodent model.
Methods: Thirty-two adult male rats were divided into the following groups: Ctrl, untreated control rats; BPH, untreated spontaneously hypertensive rats (SHRs); BPH + D, SHRs treated with dutasteride; and BPH + DS, SHRs treated with dutasteride and sildenafil. All treatments were performed during 40 days, following which the penises were collected for histomorphometrical analysis. The results were compared via one-way ANOVA with Bonferroni’s post-test, considering p values
Results: The smooth muscle density decreased by 28.6% and 21.4% in BPH + D and BPH + DS, respectively, when compared to the BPH group. The sinusoid space density reduced by 32.2% in BPH, when compared to the Ctrl group; this density was also reduced by 22.6% in BPH + D, when compared to the BPH group. The density of the elastic fibers increased 51.6% and 65.6% in BPH + D and BPH + DS, when compared to the BPH group.
Conclusion: Treatment with dutasteride promoted morphological changes in the corpus cavernous of this BPH model. Concomitant treatment with sildenafil did not prevent the morphological changes caused by dutasteride; on the contrary, it also promoted a further increase in elastic fibers.
Keywords: Benign prostatic hyperplasia; dutasteride; erectile dysfunction; penis; sildenafil.
Similar articles
da Silva MHA, Costa WS, Sampaio FJB, de Souza DB. da Silva MHA, et al. Int Braz J Urol. 2023 May-Jun;49(3):320-333. doi: 10.1590/S1677-5538.IBJU.2022.0583. Int Braz J Urol. 2023. PMID: 37115177 Free PMC article.
Da Silva MHA, Costa WS, B Sampaio FJ, De Souza DB. Da Silva MHA, et al. Asian J Androl. 2018 Sep-Oct;20(5):505-510. doi: 10.4103/aja.aja_28_18. Asian J Androl. 2018. PMID: 29893293 Free PMC article.
Yilmaz-Oral D, Onder A, Kaya-Sezginer E, Oztekin CV, Zor M, Gur S. Yilmaz-Oral D, et al. Int J Impot Res. 2022 Apr;34(3):269-276. doi: 10.1038/s41443-021-00421-y. Epub 2021 Apr 5. Int J Impot Res. 2022. PMID: 33820978
Corona G, Tirabassi G, Santi D, Maseroli E, Gacci M, Dicuio M, Sforza A, Mannucci E, Maggi M. Corona G, et al. Andrology. 2017 Jul;5(4):671-678. doi: 10.1111/andr.12353. Epub 2017 Apr 28. Andrology. 2017. PMID: 28453908 Review.
Wu C, Kapoor A. Wu C, et al. Expert Opin Pharmacother. 2013 Jul;14(10):1399-408. doi: 10.1517/14656566.2013.797965. Expert Opin Pharmacother. 2013. PMID: 23750593 Review.
Cited by
Marchon RG, Gregório BM, Costa WS, Pereira-Sampaio MA, Sampaio FJ, De Souza DB. Marchon RG, et al. Heliyon. 2023 Jun 5;9(6):e17013. doi: 10.1016/j.heliyon.2023.e17013. eCollection 2023 Jun. Heliyon. 2023. PMID: 37484244 Free PMC article.
da Silva MHA, Costa WS, Sampaio FJB, de Souza DB. da Silva MHA, et al. Int Braz J Urol. 2023 May-Jun;49(3):320-333. doi: 10.1590/S1677-5538.IBJU.2022.0583. Int Braz J Urol. 2023. PMID: 37115177 Free PMC article.
Silva MHAD, Estrada JHD, Gregório BM, Sampaio FJB, Souza DB. Silva MHAD, et al. Acta Cir Bras. 2021 Sep 15;36(7):e360703. doi: 10.1590/ACB360703. eCollection 2021. Acta Cir Bras. 2021. PMID: 34550196 Free PMC article.
